FDA: ACPSCP Meeting (HVDs, NTI Drugs) [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2007-03-21 14:56 (6101 d 10:22 ago) – Posting: # 592
Views: 7,490

Dear colleagues,

following topics will be discussed at a public meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (formerly Advisory Committee for Pharmaceutical Science) on 02 May 2007:
  1. Receive an update from the Office of Generic Drugs (OGD) on the bioequivalence of highly variable drugs,
  2. receive an update on and discuss general strategies within the OGD pertaining to the bioequivalence of narrow therapeutic index drug products, and
  3. discuss and provide comments on the topic of alcohol-induced dose dumping.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,811 posts in 4,783 threads, 1,636 registered users;
26 visitors (0 registered, 26 guests [including 6 identified bots]).
Forum time: 01:18 CET (Europe/Vienna)

No effect that requires more than ten percent accuracy in measurement
is worth investigating.    Walther Nernst

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz